Supporting patient groups and continuously improving knowledge in our therapy areas is part of our corporate responsibility.
Our ultimate goal is to discover and develop innovative therapies to improve patients' quality of life.
We specialize in the treatment of life-threatening diseases. Our patients always come first.
We offer programs for patients, families and patient organizations worldwide. They help to improve the quality of medical care.
Our product pipeline focuses on innovation and improving therapies.
Welcome to the Research & Development Team in Marburg.
At CSL Behring, we work every day as if someone’s life depends on it, because it does.
CSL Behring's biotherapeutics are manufactured in state-of-the-art facilities under strictly controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
We want you to feel comfortable at CSL.
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
Information for the press, such as press releases and press contact.
Popular search terms:
2021
Neues von CSL Behring
Hesse’s Minister of Economics Tarek Al-Wazir was deeply impressed at the award ceremony.
On 3 December, buildings around the world are shining in purple – also at CSL Behring in Marburg.
On 26 and 27 October 2021, Paul Perreault, CEO of CSL Limited was welcomed to the Marburg site.
Four European Research Programs to be Fast-Tracked in Partnership with CSL.
To mark the 3rd International Plasma Awareness Week, read these facts about the “liquid gold”.
CSL Behring in Marburg donates 5,000 COVID-19 rapid tests to the organization.
CSL Limited delivered full-year net profit of $2.375 billion.
The city of Marburg hails the accomplishments of its biotech sector with new video.
A semester abroad during my dual studies at CSL Behring.
Americas
Asia Pacific
Middle East
Europe
